Nanotechnology News and Research

RSS

Co-founder of Avidity Nanomedicines to receive 2014 Prince of Asturias Award

Avidity NanoMedicines LLC, a biopharmaceutical company pioneering a breakthrough approach to the targeted delivery of nucleic acid-based medicines, announced today that its scientific co-founder, Mark E. Davis, Ph.D., will receive the 2014 Prince of Asturias Award for Technical and Scientific Research.

9 Jun 2014

Scientists create 3-D silicon structures using water droplets

Researchers from the University of Twente in the Netherlands have taken the precise art of origami down to the microscopic scale.

4 Jun 2014

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

We already understand the many steps involved in blood clotting in great mechanistic detail. The process of blood vessels closing off in response to injury is necessary for preserving life, but blood platelets that are over-active, or activated inappropriately because of unstable plaque, can lead to heart attacks and strokes.

3 Jun 2014

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Pioneering 'tweezers' that use ultrasound beams to grip and manipulate tiny clusters of cells under electronic, push-button control could lead to life-changing medical advances, such as better cartilage implants that reduce the need for knee replacement operations.

31 May 2014

Scientists develop 3-D artificial enzyme cascade that mimics biochemical pathway using DNA molecules

Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.

26 May 2014

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Alzheimer's is a progressive brain disease that affects older adults, slowly destroys their memories and may cause dementia. According to estimates from the National Institutes of Health (NIH), the disease may affect as many as 5.1 million Americans.

22 May 2014

Nanogel heals burn wounds faster

Researchers at the Institute of Bioengineering and Nanotechnology have developed a nanogel that can accelerate the healing of burn wounds to minimize the risk of infection and scarring. The technology is based on IBN’s proprietary self-assembling ultrashort peptide technology, which are short sequences of amino acids.

16 May 2014

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes.

9 May 2014

TSRI scientists create bacteria with expanded DNA code

Scientists at The Scripps Research Institute have engineered a bacterium whose genetic material includes an added pair of DNA “letters,” or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.

8 May 2014

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

Bioengineers at the University of Rome Tor Vergata and the University of Montreal have used DNA to develop a tool that detects and reacts to chemical changes caused by cancer cells and that may one day be used to deliver drugs to tumor cells.

8 May 2014

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

New findings from an in vitro study, led by researchers at Brigham and Women's Hospital (BWH), show that the combination of statins and eicosapentaenoic acid (EPA), an omega-3 fatty acid, may potentially reduce cardiovascular risk.

2 May 2014

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

A study to investigate how nanoparticles could be used to improve the diagnosis and treatment of cardiovascular disease has received -3 million funding.

2 May 2014

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies — Momenta Pharmaceuticals, Cerulean Pharma, and Visterra — share a similar goal.

1 May 2014

Researchers use gold nanoparticles to detect, measure cancer levels in living cell

Purdue University researchers have developed a way to detect and measure cancer levels in a living cell by using tiny gold particles with tails of synthetic DNA.

25 Apr 2014

Measuring tumors' oxygen levels could help doctors make decisions about treatments

Unlike healthy cells, cancer cells thrive when deprived of oxygen. Tumors in low-oxygen environments tend to be more resistant to therapy and spread more aggressively to other parts of the body.

25 Apr 2014

Kala Pharmaceuticals completes $22.5 million Series B financing

Kala Pharmaceuticals, Inc., a leading developer of innovative ophthalmic products based on the company's proprietary Mucus Penetrating Particle (MPP) platform technology, today announced it has completed a $22.5 million Series B financing.

23 Apr 2014

Scientists develop DNA nanodevices that survive body's immune defenses

It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system.

23 Apr 2014

Researchers develop first size-based form of chromatography using nanodot technology

Using nanodot technology, Berkeley Lab researchers have demonstrated the first size-based form of chromatography that can be used to study the membranes of living cells.

23 Apr 2014

IMPAKT breast cancer conference abstracts online

Xenografts and mathematical modelling; liquid biopsy; nanotechnology; next generation genomics- Science is running fast and the impact of new technologies in the care of patients with breast cancer will be at the core of the sixth edition of the IMPAKT conference on translational research in breast cancer.

22 Apr 2014

Sandia develops credit-card-sized anthrax detection cartridge to small business makes

A credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories and recently licensed to a small business makes testing safer, easier, faster and cheaper.

21 Apr 2014

Nanotechnology News and Research

Co-founder of Avidity Nanomedicines to receive 2014 Prince of Asturias Award

Scientists create 3-D silicon structures using water droplets

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

Ultrasound beam 'tweezers' can grip and manipulate tiny clusters of cells

Scientists develop 3-D artificial enzyme cascade that mimics biochemical pathway using DNA molecules

Researcher receives $1.5M grant from NIH to find clues into causes of Alzheimer's

Nanogel heals burn wounds faster

Luminescent nanocrystals tags with high-speed scanning technology detects multiple viruses within minutes

TSRI scientists create bacteria with expanded DNA code

Bioengineers develop tool that reacts to chemical changes caused by cancer cells

New findings show combination of statins and omega-3 fatty acid may potentially reduce cardiovascular risk

Study investigates how nanoparticles could be used to improve diagnosis, treatment of cardiovascular disease

Biotech to the rescue

Researchers use gold nanoparticles to detect, measure cancer levels in living cell

Measuring tumors' oxygen levels could help doctors make decisions about treatments

Kala Pharmaceuticals completes $22.5 million Series B financing

Scientists develop DNA nanodevices that survive body's immune defenses

Researchers develop first size-based form of chromatography using nanodot technology

IMPAKT breast cancer conference abstracts online

Sandia develops credit-card-sized anthrax detection cartridge to small business makes

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News